Inspire Investing, LLC Repligen Corp Transaction History

Inspire Investing, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	BUY	$138.42 - $180.31 $61,458 - $80,057	444 Added 5.0%	9,320 $1.32 Million
Q1 2023 Apr 24, 2023	BUY	$154.26 - $198.1 $109,987 - $141,245	713 Added 8.73%	8,876 $1.49 Million
Q4 2022 Jan 26, 2023	BUY	$162.42 - $220.56 $214,394 - $291,139	1,320 Added 19.29%	8,163 $0
Q3 2022 Nov 07, 2022	BUY	$160.42 - $256.21 $1.1 Million - $1.75 Million	6,843 New	6,843 $1.28 Million
Q2 2021 Aug 10, 2021	SELL	$165.87 - $220.95 $488,984 - $651,360	-2,948 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$180.37 - $226.26 $216,083 - $271,059	1,198 Added 68.46%	2,948 $573,000
Q4 2020 Feb 12, 2021	BUY	$148.08 - $206.57 $259,140 - $361,497	1,750 New	1,750 $335,000

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.59B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

Stay updated on Inspire Investing, LLC with notifications on news.